72 related articles for article (PubMed ID: 26536962)
1. Trends in presentation, management and survival of patients with de novo metastatic breast cancer in a Southeast Asian setting.
Bhoo-Pathy N; Verkooijen HM; Tan EY; Miao H; Taib NA; Brand JS; Dent RA; See MH; Subramaniam S; Chan P; Lee SC; Hartman M; Yip CH
Sci Rep; 2015 Nov; 5():16252. PubMed ID: 26536962
[TBL] [Abstract][Full Text] [Related]
2. Modelling excess mortality among breast cancer patients in the North East Region of Peninsular Malaysia, 2007-2011: a population-based study.
Hanis TM; Yaacob NM; Hairon SM; Abdullah S; Nordin N; Abdullah NH; Ariffin MFM
BMC Public Health; 2019 Dec; 19(1):1754. PubMed ID: 31888561
[TBL] [Abstract][Full Text] [Related]
3. A comparison of treatment allocation and survival between younger and older patients with HER2-overexpressing de novo metastatic breast cancer.
Lemij A; de Glas N; Kroep J; Siesling S; van den Bos F; Bastiaannet E; Liefers GJ; Portielje J
J Geriatr Oncol; 2024 Jun; 15(6):101805. PubMed ID: 38852378
[TBL] [Abstract][Full Text] [Related]
4. Illuminating the breast cancer survival rates among Southeast Asian women: A systematic review and meta-analysis spanning four decades.
Quang DT; Luong Thi T; Nguyen Di K; Vu Thi Quynh C; Nguyen Thi Hoa H; Phan Ngoc Q
Curr Probl Cancer; 2024 Feb; 48():101062. PubMed ID: 38309146
[TBL] [Abstract][Full Text] [Related]
5. Locoregional therapy in de novo metastatic breast cancer. The unanswered question.
Cardoso MJ; Mokbel K
Breast; 2021 Aug; 58():170-172. PubMed ID: 34158166
[No Abstract] [Full Text] [Related]
6. Survival in Patients With De Novo Metastatic Prostate Cancer.
Schoen MW; Montgomery RB; Owens L; Khan S; Sanfilippo KM; Etzioni RB
JAMA Netw Open; 2024 Mar; 7(3):e241970. PubMed ID: 38470422
[TBL] [Abstract][Full Text] [Related]
7. Re: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB).
Neven P; Han S; Borremans K; Van Houdt M; Khan SA
Breast Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38879862
[No Abstract] [Full Text] [Related]
8. Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
Brandão M; Martins-Branco D; De Angelis C; Vuylsteke P; Gelber RD; Van Damme N; van Walle L; Ferreira AR; Lambertini M; Poggio F; Verhoeven D; Barbeaux A; Duhoux FP; Wildiers H; Caballero C; Awada A; Piccart-Gebhart M; Punie K; de Azambuja E
Breast Cancer Res Treat; 2024 Jul; 206(1):207. PubMed ID: 38592543
[No Abstract] [Full Text] [Related]
9. Editorial Comment to Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors.
Kishida T
Int J Urol; 2024 Jun; ():. PubMed ID: 38943341
[No Abstract] [Full Text] [Related]
10. Survival nomogram for patients with
Ning L; Liu Y; Hou Y; Wang M; Shi M; Liu Z; Zhao J; Liu X
Cancer Pathog Ther; 2023 Oct; 1(4):253-261. PubMed ID: 38327599
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram and Risk Classification System Predicting the Prognosis of Patients with De Novo Metastatic Breast Cancer Undergoing Immediate Breast Reconstruction: A Surveillance, Epidemiology, and End Results Population-Based Study.
Zhao J; Bian S; Di X; Xiao C
Curr Oncol; 2023 Dec; 31(1):115-131. PubMed ID: 38248093
[TBL] [Abstract][Full Text] [Related]
12. De novo metastatic breast cancer in men vs women: a Swedish population-based cohort study.
Schiza A; Fredriksson I; Sund M; Valachis A
JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37490458
[TBL] [Abstract][Full Text] [Related]
13. Aggressive local therapy for
Liu B; Liu H; Liu M
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37449542
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer.
Almasri H; Erjan A; Abudawaba H; Ashouri K; Mheid S; Alnsour A; Abdel-Razeq H
Breast Cancer (Dove Med Press); 2022; 14():363-373. PubMed ID: 36340331
[TBL] [Abstract][Full Text] [Related]
15. Theory and Practice of Integrating Machine Learning and Conventional Statistics in Medical Data Analysis.
Dhillon SK; Ganggayah MD; Sinnadurai S; Lio P; Taib NA
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292218
[TBL] [Abstract][Full Text] [Related]
16. Targeting metabolism: A potential strategy for hematological cancer therapy.
Tang X; Chen F; Xie LC; Liu SX; Mai HR
World J Clin Cases; 2022 Apr; 10(10):2990-3004. PubMed ID: 35647127
[TBL] [Abstract][Full Text] [Related]
17. Predicting Characteristics Associated with Breast Cancer Survival Using Multiple Machine Learning Approaches.
Haque MN; Tazin T; Khan MM; Faisal S; Ibraheem SM; Algethami H; Almalki FA
Comput Math Methods Med; 2022; 2022():1249692. PubMed ID: 35509861
[TBL] [Abstract][Full Text] [Related]
18. Filamin A Is a Potential Driver of Breast Cancer Metastasis
Zhou J; Wu L; Xu P; Li Y; Ji Z; Kang X
Front Oncol; 2022; 12():836126. PubMed ID: 35359350
[TBL] [Abstract][Full Text] [Related]
19. A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.
Shawky MS; Huo CW; Henderson MA; Redfern A; Britt K; Thompson EW
Breast Cancer Res Treat; 2019 Sep; 177(2):251-276. PubMed ID: 31177342
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
